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Abstract
Background
Malaria control through use of long-lasting insecticidal nets (LN) is threatened by the selec-
tion of anopheline mosquitoes strongly resistant to pyrethroid insecticides. To sustain future
effectiveness it is essential to identify and evaluate novel insecticides suitable for nets. Mix-
tures of two insecticides with contrasting mode of action have the potential to kill resistant
vectors and restore transmission control provided the formulation can withstand regular
washing over the net’s life span.
Method
The efficacy of a novel mixture LN, Interceptor® G2, that combines the pyrrole chlorfenapyr
and pyrethroid alpha-cypermethrin was evaluated under controlled household conditions
(experimental hut trial) and by laboratory bioassay against pyrethroid resistant An. gambiae
in Benin before and after standardized washing. Comparison arms included standard alpha-
cypermethrin LN, nets hand-treated with chlorfenapyr-only and untreated nets.
Results
The chlorfenapyr-alphacypermethrin LN demonstrated improved efficacy and wash resis-
tance compared to a standard alpha-cypermethrin LN against pyrethroid resistant mosqui-
toes (resistance ratio 207). In experimental hut trial alpha-cypermethrin LN killed only 20%
(95% CI 15–26%) of host-seeking An. gambiae whilst mixture LN killed 71% (95% CI 65–
77%). Mixture LN washed 20 times killed 65% (95% CI 58–71%), and thus intensive wash-
ing reduced efficacy by only 6% (95% CI 1.3–11%). The chlorfenapyr net killed 76% (95%
CI 70–81%). Personal protection and blood feeding inhibition did not differ between mixture
and pyrethroid LN; however, the mixture LN was 2.5 (95% CI: 2.1–3.1) times more protec-
tive than untreated nets. Standard WHO cone bioassays conducted during day time hours
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failed to anticipate field efficacy but overnight tunnel tests successfully predicted mixture LN
and chlorfenapyr net efficacy in field trials.
Conclusion
Interceptor® G2 LN demonstrates the potential to control transmission and provide commu-
nity protection over the normal lifespan of long lasting nets where standard pyrethroid LN
show signs of failing due to resistance.
Introduction
Long-lasting insecticidal nets (LN) are the most widely used public health interventions for
malaria prevention [1]. In countries of sub-Saharan Africa the estimated proportion of people
with access to LN in their homes in 2015 was 67% and the proportion sleeping under LN was
55% compared to less than 2% in 2000. Malaria infection prevalence among African children
is estimated to have declined from 33% to 16% and under-5 all-cause mortality by 48% over
the same period. The massive scale up of LN during the last decade has made a major contribu-
tion to these declines. Recent figures estimate that 427 million LN were distributed in Africa in
2012–2014. The current effectiveness of LN is entirely dependent on a single class of insecti-
cide, the pyrethroids, and with the high level of LN coverage the selection pressure on mos-
quito vector populations is immense. Subsequently, resistance to pyrethroids has increased in
distribution and strength [2, 3]. Of the 42 African countries deploying LN, pyrethroid resis-
tance was reported in 29 countries in 2010–2015. While a negative epidemiological impact of
pyrethroid resistance on malaria control has yet to be confirmed [1, 4], an increasing number
of reports show that pyrethroid resistance is capable of reducing the effectiveness of LNs used
against host seeking mosquitoes [5–7], and leading brands are giving less personal protection
and reduced vector mortality rates compared to areas of pyrethroid susceptibility [8, 9].
If LN are to remain viable for malaria transmission control in the future it is essential that
new public health insecticides are identified and developed to address the growing problem of
resistance. One alternative insecticide to pyrethroids that is presently under development is
chlorfenapyr, a member of the pyrrole class [10]. Unlike other adulticides chlorfenapyr is not
neurotoxic but owes its toxicity to disruption of cellular respiration and oxidative phosphory-
lation in mitochondria [10]. Owing to its unique mode of action, chlorfenapyr is active against
pyrethroid resistant and susceptible mosquitoes [11, 12]. On mosquito netting chlorfenapyr is
toxic to mosquitoes but lacks the property of excito-repellency crucial for reducing mosquito
biting rates and providing personal protection to net users [11]. On mosquito nets hand
treated with the chlorfenapyr-pyrethroid mixture and tested in experimental huts the pyre-
throid component provided excito-repellency whilst the chlorfenapyr component restored
insecticidal activity against pyrethroid resistant mosquitoes [12, 13]. Such mixture nets have
potential for insecticide resistance management because phenotypes that survive contact with
one insecticide due to resistance should be killed by the other insecticide provided they are not
resistant to both [14]. To date there is no recorded occurrence of resistance to chlorfenapyr in
any species of anopheline or culicine mosquito [11–13, 15–18].
Based on the encouraging activity of the hand-treated mixture nets a product development
partnership was established between BASF SE, the Innovative Vector Control Consortium and
the London School of Hygiene & Tropical Medicine to develop a long-lasting mixture LN to
combine chlorfenapyr and alpha-cypermethrin in a wash resistant formulation which would
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address the problem of malaria control in countries with high level insecticide resistance. The
World Health Organization (WHO) sets criteria for LN to attain to be recommended for pub-
lic health use. The WHO Pesticide Evaluation Scheme (WHOPES) stipulates that new candi-
date pyrethroid LN and mixture LN should achieve efficacy in experimental hut studies equal
or better than standard LN subjected to 20 standardized washes before qualifying as fit for
malaria control [19]. The WHO Vector Control Action Group (VCAG) which advises WHO
on new vector control tools goes one step further and stipulates that for use against pyrethroid
resistant vector populations the mixture LN should demonstrate efficacy (mosquito mortality
or prevention of blood-feeding) significantly greater than standard pyrethroid-only LN [20].
The objectives of the studies reported here were to evaluate the efficacy of the mixture
chlorfenapyr-alphacypermethrin LN, Interceptor1 G2 LN, in laboratory tests and experimen-
tal hut trial against a well characterized population of pyrethroid-resistant Anopheles gambiae
according to the criteria of WHOPES and VCAG.
Materials and Methods
Study Site and Experimental Huts
The Phase II experimental hut station is situated in a rice irrigation zone near Cove´ (7˚140N,
2˚180E), Benin. The vector species are Anopheles coluzzii (formerly An gambiae M form) and
An. gambiae s.s. (S form) [9]. The frequency of the 1014F kdr allele is 89% and the P450
CYP6P3 associated with metabolic resistance is also present.
The WHO Phase II evaluation of Interceptor G2 was performed in 8 experimental huts
of the West African design [19]. The operating principle of the huts is to allow unrestricted
access of host seeking mosquitoes though baffled entry slits and to capture exiting survivors in
veranda traps, and to deny entry to scavenging ants.
Insecticide resistance tests
Cylinder tests with WHO test papers were used to assess the frequency of pyrethroid resistance
of mosquitoes, reared from sites near the huts [21]. To determine the intensity of resistance,
the adults were tested in CDC bottle bioassays treated with a range of alpha-cypermethrin
doses [22]. Mosquitoes were exposed for 1 h and mortality recorded 24 h later. An. gambiae s.l.
were identified to species and genotyped for kdr resistance.
Net treatments and trial procedure
The Interceptor1 G2 LN, Interceptor LN and chlorfenapyr formulation (Phantom 240g/L SC)
were supplied by BASF SE. The target concentrations were 100 mg/m2 alpha-cypermethin and
200 mg/m2 chlorfenapyr on Interceptor1 G2 LN, 200 mg/m2 alpha-cypermethrin on Intercep-
tor1 LN and 200 mg/m2 on the chlorfenapyr net. All nets were 100 denier polyester.
The following 8 treatment arms were compared in the experimental huts: Interceptor1 G2
LN unwashed, washed 15 times and washed 20 times; Interceptor1 LN unwashed, washed 15
times and washed 20 times; chlorfenapyr hand treated net; untreated net.
Washing of LNs was done according to WHO Phase II protocols [19]. The interval between
washes was 1 day which is the established regeneration time for Interceptor G2 and Interceptor
LN [23]. Each net was cut with six holes of 4 cm diameter to simulate wear and tear. Treat-
ments were rotated between huts each week and sleepers rotated each night using a random-
ized latin square design to adjust for any variation in attractiveness to mosquitoes. Each
morning mosquitoes were collected and held for a 72 h to record any delayed mortality.
Chlorfenapyr-Alphacypermethrin Treated Net
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The primary outcomes were: entry and exiting rates, percentage mortality relative to the
total collected, percentage blood-feeding inhibition, percentage personal protection.
Chemical analysis
Nets were sampled before and after washing and after the trial [19]. Determination of alpha-
cypermethrin and chlorfenapyr content was performed at BASF SE applying CIPAC 454/LN
method.
Supporting bioassay tests on nets used in the trials
The efficacy of the 8 treatments was also tested under laboratory conditions applying standard
WHO cone and tunnel bioassays against pyrethroid susceptible (Kisumu) and resistant (Cove´)
An gambiae strains.
For each type of net and wash point, 100 females were subjected to 3 min exposure in cone
bioassays in replicates of 5 mosquitoes per cone and 150 were tested in tunnel tests in replicates
of 50 mosquitoes per test in accordance with WHO guidelines [19]. The tunnels were divided
into two sections by a netting frame punctured with 9 holes slotted across the tunnel. In one
section an anaesthetized guinea pig was housed unconstrained in a cage to attract mosquitoes
from the release section overnight. Test conditions were 27 ± 2˚C and 75 ± 10% RH. Mosquito
mortality was recorded after 24h and 72h holding periods.
Statistical analysis
Estimates of LD50 and resistance ratios were generated using probit analysis (Polo Plus, LeOra
Software). Cone and tunnel test were analyzed using logistic regression for grouped data
adjusting for clustering within replicate tests (STATA/IC 12, Stata Corp., College Station,
USA).
Proportional outcomes in the experimental hut trial (net penetration, blood-feeding, exiting
and mortality) related to each treatment were assessed using binomial generalized linear
mixed models (GLMM) with a logit link function fitted using the ‘lme4’ package for R (version
2.15.0). In addition to the fixed effect of each treatment, each model included random effects
to account for variation between the huts, sleepers, the weeks of the trial, and for variation not
explained by the other terms. Comparison between numeric outcomes (deterrence, personal
protection) between treatments was analyzed using negative binomial regression with adjust-
ment for variation in the covariates above.
Ethical clearance
Approved by the Ethical Committees of LSHTM, UK and Ministry of Health, Benin. The
experimental hut volunteer sleepers gave written informed consent before participating and
were provided with chemoprophylaxis during the study
Results
WHO susceptibility tests and intensity dose–response bioassay
To determine the frequency and strength of resistance to pyrethroids in the local strain of An.
gambiae s.l. colonized from rice fields near the experimental huts, adult mosquitoes 2–3 days
old were tested in WHO cylinder tests and CDC intensity bottle bioassays [21, 22].
After confirming that exposure to diagnostic concentrations of pyrethroid insecticides
would kill 100% of the susceptible An gambiae Kisumu strain, An gambiae s.l. Cove´ strain were
Chlorfenapyr-Alphacypermethrin Treated Net
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exposed to the permethrin and deltamethrin test papers. Percentage mortality was 8% and
12% respectively demonstrating a high frequency of pyrethroid resistance.
In the resistance intensity bottle bioassays with technical grade alpha-cypermethrin the
LC50 were 0.0004μg for Kisumu and 0.083μg for Cove´ strain demonstrating a resistance ratio
of 207 (CI: 120–316) for An gambiae s.l. Cove´ (Table 1).
Experimental hut trial
Mosquito entry and exiting from huts. The efficacy of each type of net (Interceptor1 G2
LN, Interceptor1 LN and chlorfenapyr CTN) was assessed under carefully controlled house-
hold-like conditions. Using volunteers sleeping overnight in experimental huts in Cove´, the
nets were washed up to 20 times and tested for their ability to prevent biting and kill wild,
host-seeking pyrethroid-resistant An. gambiae s.l. mosquitoes) that entered the huts to feed
[19]. These experimental hut studies (presented in Tables 2 and 3 and Fig 1) enabled the mos-
quito nets to be evaluated for their capacity to deter mosquito entry, inhibit biting and blood-
feeding, and kill the mosquito vector.
An average of 858 female mosquitoes per treatment were collected over 72 nights of the
trial (Table 2). The majority (98.8%) were Anopheles coluzzii Coetzee & Wilkerson (formerly
Anopheles gambiae M form). There were no major differences in the numbers collected
between treatments. Although more were collected from huts with Interceptor1 LN and Inter-
ceptor G2 LN that had been washed 20 times, there was no evidence of deterred hut entry with
treated nets compared to the untreated net control (Table 2).
Up to 40% of mosquitoes were collected from inside the nets (6 holes had been deliberately
cut into the sides of each net to mimic wear and tear). The greatest number were found inside
the untreated nets and the fewest inside the unwashed Interceptor1 LN and Interceptor1 G2
LN presumably due to excito-repellent effect of the pyrethroid.
Exiting rates into the veranda trap were generally higher with the pyrethroid treated nets
(Interceptor1 LN and Interceptor1 G2 LN) and least with the untreated net. There was an
Table 1. Intensity of pyrethroid (alpha-cypermethrin) resistance in Anopheles gambiae s.l. from Cove´. Lethal concentrations are expressed in μg/ml.
Strain Slope (S.E.) LC50 (95% CI) LC95 (95% CI) Resistance ratio at LC50 (95% CI)
Kisumu 1.08 (0.15) 0.0004 (0.000–0.017) 0.011 (0.002–3.644) -
Cove´ 1.32 (0.35) 0.083 (0.048–0.106) 1.493 (0.881–4.423) 207 (120–316)
doi:10.1371/journal.pone.0165925.t001
Table 2. Number of wild Anopheles gambiae s.l. females entering and leaving the huts in the experimental hut trial.
Treatment Number of
washes
Total females
caught
Average caught per night
(geometric mean)
Percentage in net
(CI)
Percentage exiting
(CI)
Induced
exiting %
Untreated net 0 673 9.4 (6.7)a 40 (34–46)a 32 (27–36)a -
Chlorfenapyr
CTN
0 713 10.4 (6.4)a 24 (19–29)d 50 (45–55)c 27
Interceptor LN 0 631 9.3 (5.9)a 10 (7–13)e 59 (54–64)bd 40.4
15 799 10.4 (7.6)ac 22 (18–27)bd 51 (46–56)c 28.6
20 950 13.4 (9.9)bc 19 (15–24)bc 51 (46–56)c 28.6
Interceptor G2
LN
0 697 10.4 (6.7)ad 10 (17–13)e 62 (57–67)d 44.7
15 616 9.1 (6.9)a 18 (14–23)bc 59 (53–64)bd 39.7
20 929 13.0 (8.5)bcd 16 (12–20)c 56 (51–60)bc 35.4
Values in the same column not sharing a letter superscript differ significantly (P < 0.05)
doi:10.1371/journal.pone.0165925.t002
Chlorfenapyr-Alphacypermethrin Treated Net
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inverse trend of reduced exiting with increasing number of washes. Chlorfenapyr also
appeared to stimulate exiting compared to the untreated net.
Blood feeding inhibition and personal protection. Percentage blood feeding of mosqui-
toes was 47–60% less with Interceptor1 G2 LN and Interceptor1 LN relative to the untreated
net (Fig 1a). Blood feeding inhibition in mosquitoes and personal protection from mosquito
bites were both significant (P = 0.0001) across all treatments relative to the untreated net
(Table 3). There was no significant difference in percentage blood feeding between Intercep-
tor1 G2 LN and Interceptor1 LN over the 20 washes (P = 0.26).
There was an inverse trend of reduced personal protection with increasing number of
washes that was significant for both Interceptor1 G2 LN (P = 0.012) and Interceptor1 LN
(P = 0.0001). The chlorfenapyr CTN provided 37% more personal protection than the
untreated net (P = 0.0001). There was no difference in personal protection between Intercep-
tor1 LN and Interceptor1 G2 LN at any wash stage (P = 0.46).
Table 3. Blood feeding inhibition, personal protection and mortality rates of Anopheles gambiae s.l. due to insecticide treated nets in the experi-
mental hut trial.
Treatment Number of
washes
Blood-feeding inhibition
% (CI)
Personal
protection %
Mortality %, corrected for control
mortality (CI)
Mortality as % of all
mortality
Untreated net 0 0a 0a 0a 56
Chlorfenapyr
CTN
0 43 (34–52)b 36.7e 76 (70–81)f 67
Interceptor LN 0 57 (48–65)c 62.5c 76 (70–81)f 67
15 54 (46–62)c 47.1bce 11 (8–16)d 69
20 47 (38–54)b 22ab 13 (9–17)d 70
Interceptor G2
LN
0 60 (52–68)c 59.2c 71 (65–77)c 72
15 48 (39–56)bc 53.2bce 68 (62–74)bc 67
20 50 (41–58)bc 34.4be 65 (58–71)b 67
Values in the same column not sharing a letter superscript differ significantly (P<0.05)
doi:10.1371/journal.pone.0165925.t003
Fig 1. Experimental hut trials against wild Anopheles gambiae s.l. with Interceptor® G2 and other nets. (A) Percentage blood-feeding, (B)
Percentage mortality.
doi:10.1371/journal.pone.0165925.g001
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Mosquito mortality. Mortality with the untreated control net after a 72h holding period
was 5% (Fig 1b). The mortality induced by the alpha-cypermethrin LN (Interceptor LN)
against pyrethroid resistant An gambiae s.l was only 24% when unwashed (20% after correct-
ing for control mortality) decreasing to 17% after 20 washes (13% after correction) (Table 3).
Mortality was highest with the chlorfenapyr CTN (77%). Mortality with the unwashed chlorfe-
napyr-alpha-cypermethrin LN (Interceptor G2 LN) was 73% (71% after correction). There was
no significant change in mortality with Interceptor1 G2 LN over 15 washes (recorded as 70%
or 68% after correction) (P = 0.31) but a small change was evident after 20 washes (66%, or
65% after correction) which was significant (P = 0.02). This indicates that the chlorfenapyr
component made the largest contribution to mortality of pyrethroid resistant An gambiae s.l.
and the formulation was wash resistant over 20 washes. Of all mosquitoes killed by the LN/
CTN treatments, 67 to 72% were collected dead from the huts on the morning of collection.
This proportion did not differ between alpha-cypermethrin-only and chlorfenapyr-only treat-
ments (Table 3). The insecticide-induced mortality was more ‘immediate’ (within 6-12h of
contact with the net) than ‘delayed’ (after 24-72h holding) and the delayed mortality was not
chlorfenapyr-specific but applied to pyrethroid too.
Chemical analysis and bio-activity of nets tested in experimental huts
The insecticide content of representative nets before washing, after washing and after trialing
in the huts are shown in Fig 2a. Chemical analysis confirms that the alpha-cypermethrin con-
tent of unused Interceptor1 LN (165 ± 12 mg/m2) and unused Interceptor1 G2 LN (96 ± 5
mg/m2) were within ±25% of target specification and hence met the tolerance limits required
by WHO [19]. The initial chlorfenapyr content of the CTN (233 ± 7 mg/m2) and Interceptor
G2 LN (218 ± 7 mg/m2) were also within ± 25% of specification. Nets used in the experimental
huts could only be sampled for chemical analysis after trial completion. Among these, the
alpha-cypermethrin content of the unwashed Interceptor1 LN (161 ± 15 mg/m2) and
unwashed Interceptor1 G2 LN (79 ± 1.5 mg/m2) and the chlorfenapyr content of the CTN
Fig 2. Insecticide content of Interceptor® G2 LN and other nets washed up to 20 times used in the hut trial. (A) Chemical analysis
(mean ± standard error). (B) Scanning electron microscope images of Interceptor® G2 (courtesy of BASF SE) showing chlorfenapyr (elongate) and
alphacypermethrin (short) crystals on netting fibres.
doi:10.1371/journal.pone.0165925.g002
Chlorfenapyr-Alphacypermethrin Treated Net
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(213 ± 12 mg/m2) and unwashed Interceptor1 G2 LN (162 ± 3 mg/m2) were within target
specification. After 15 and 20 washes the alpha-cypermethrin content of Interceptor1 LN had
decreased to 29 and 14 mg/m2 respectively or 18% and 9% of the initial content. After 15 to 20
washes of Interceptor1 G2 LN the alpha-cypermethrin content had decreased to 63 ± 5 mg/
m2 or 80% of the initial content of unwashed Interceptor1 G2 LN, indicating a stronger bind-
ing of pyrethroid in Interceptor1 G2 LN compared to Interceptor1 LN. After 15 to 20 washes
the chlorfenapyr content of Interceptor1 G2 LN had decreased to 102 ± 7 mg/m2 or 63% of
the unwashed net, indicating a high wash retention of chlorfenapyr on polyester netting.
The small decrease in percentage mortality over 20 washes with Interceptor1 LN (from 20
to 13%) appears to be independent of the change in alpha-cypermethrin content (from 161 to
14 mg/m2) which decreased by an order of magnitude over this wash interval. This reflects
how pyrethroid resistance enabled mosquitoes to survive across a wide range of insecticide
concentrations. In contrast, the 63% reduction of chlorfenapyr content on Interceptor1 G2
LN after 15–20 washes (from 162 to 102 mg/m2) led to only a small change in mortality (from
71 to 65%) indicating the minimum effective content of chlorfenapyr was below this range.
Fig 2b shows the Interceptor1 G2 LN netting under the scanning electron microscope with
pictures taken at different magnifications. Individual crystals of active ingredient are visible on
the surface, where they are accessible to mosquito contact on touching the netting. Some of the
binder formulation is perceived to bridge individual fibers of the multifilament yarn used for
producing polyester netting.
Supplementary laboratory bioassays
Cone and tunnel tests. The purpose of the supplementary bioassays was to sample netting
from the Interceptor1 G2 LN, Interceptor1 LN and chlorfenapyr CTN that had been used in
the experimental hut trial to: 1) evaluate efficacy against pyrethroid resistant and susceptible
strains in mosquito bioassay, and 2) examine the capacity of laboratory bioassay to predict the
performance of Interceptor1 G2 LN and its constituent insecticides under experimental hut
conditions.
Fig 3a and 3b present the proportions of pyrethroid-susceptible and resistant mosquitoes
that were killed 72 h after a 3 minute exposure to insecticide treated netting in WHO cone
Fig 3. Mortality rates of Anopheles gambiae in cone tests with 3 min exposure to Interceptor® G2 and other nets. (A) Susceptible Kisumu
strain. (B) Resistant Cove´ strain.
doi:10.1371/journal.pone.0165925.g003
Chlorfenapyr-Alphacypermethrin Treated Net
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bioassays. On testing unwashed netting against the susceptible Kisumu strain, mortality was
100% with Interceptor1 LN, 58% with Interceptor1 G2 LN and 42% with chlorfenapyr CTN.
On testing unwashed netting against the pyrethroid resistant Cove´ strain, mortality did not
exceed 12% with any of Interceptor1 LN and G2 LN or CTN. Washing Interceptor1 LN and
Interceptor1 G2 20 times made little difference to the proportions killed of either mosquito
strain relative to unwashed LN.
Fig 4a and 4b show the proportions of pyrethroid-susceptible and resistant An. gambiae
killed 72h after exposure to the same pieces of insecticide treated netting in overnight tunnel
tests. Tests against the pyrethroid susceptible Kisumu strain recorded high mortality with each
type of netting (94–100%). Tests against the pyrethroid resistant Cove´ strain recorded 22%
mortality with the unwashed Interceptor1 LN, 82% with the unwashed Interceptor1 G2 and
77% with the chlorfenapyr CTN. Tests with LN washed up to 20 times showed up to 25%
reduction in mortality.
Blood feeding inhibition in the tunnel tests with the susceptible Kisumu strain ranged from
77–100% and was high for both types of LN (Fig 4c). Blood feeding inhibition with the resis-
tant strain was less, ranging from 44–67% and was similar for both types of LN (Fig 4d). The
feeding inhibition seemed largely due to the pyrethroid although chlorfenapyr was also inhibi-
tory to some extent in the CTN.
Comparing cone and tunnel test mortality, resistance to pyrethroid in the Cove´ strain was
strongly expressed in each type of bioassay system. The efficacy of the chlorfenapyr CTN was
strongly expressed in the tunnel test but was poorly expressed in the cone test; this trend was
consistent in both the susceptible and resistant strain and was therefore independent of
Fig 4. Response of Anopheles gambiae in tunnel tests with Interceptor® G2 and other nets. (A) Mortality of susceptible strain. (B) Mortality of
resistant strain. (C) Blood-feeding rate of susceptible strain. (D) Blood-feeding rate of resistant strain.
doi:10.1371/journal.pone.0165925.g004
Chlorfenapyr-Alphacypermethrin Treated Net
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pyrethroid resistance. The efficacy of Interceptor G2, being a mixture of chlorfenapyr and
pyrethroid, was more evident in the tunnel than the cone and higher in the pyrethroid suscep-
tible than the resistant strain.
Comparison with hut trial results. Comparing the laboratory bioassay results on the
pyrethroid resistant strain with the experimental hut results on the pyrethroid resistant wild
population, both types of bioassay predicted the response in the hut to the pyrethroid-only LN,
the tunnel more than the cone. Mortality was 12% in the cone, 22% in the tunnel and 24% in
the hut against the unwashed Interceptor LN and 5% in the cone, 18% in the tunnel and 17%
in the hut against the 20 times washed Interceptor LN. However, when tested against the chlor-
fenapyr CTN or mixture LN, the tunnel test was the better predictor of hut mortality than was
the cone. Mortality with the unwashed chlorfenapyr CTN was 12% in the cone, 77% in the tun-
nel and 77% in the hut, and with unwashed Interceptor G2 it was 5% in the cone, 82% in the
tunnel and 72% in the hut; the trend between assay systems was similar with the 20 times
washed Interceptor1 G2.
The blood feeding rates and feeding inhibition with the resistant Cove´ strain in the tunnel
(Fig 4d) were similar to the blood feeding rates and feeding inhibition observed with wild
Cove´ An gambiae in the experimental huts (Fig 1a).
This series of tests demonstrates that the chlorfenapyr component of Interceptor1 G2 LN
makes the major contribution to controlling pyrethroid resistant An gambiae. The tunnel tests
were highly predictive of efficacy in experimental huts whilst cone bioassays were poorly pre-
dictive. The tunnel tests against resistant and susceptible strains showed that Interceptor1 G2
LN goes a long way to restoring the efficacy of LN against pyrethroid resistant mosquitoes.
Discussion
Earlier experimental hut trials of mosquito nets hand treated with alpha-cypermethrin and
chlorfenapyr formulations in aqueous solution provided the proof of concept that mixtures of
the two insecticides on nets would kill and protect against African mosquitoes in regions
where the development of pyrethroid resistance is undermining pyrethroid treated nets and
threatening malaria control [12, 13]. Hand treated nets are impractical at scale and have been
superseded by long lasting insecticidal nets that can withstand multiple washes and stay effec-
tive for the lifespan of the net [1, 19]. The objective of the present study was to evaluate in
small-scale field trial—with supporting exploratory bioassay techniques—the efficacy and
wash resistance of the long lasting mixture net, Interceptor G2 LN, compared to standard
pyrethroid-only LN and to determine whether the mixture LN meets the efficacy criteria set by
the World Health Organization for malaria control purposes [19, 20].
Experimental hut trial is the gold standard technique for evaluating the efficacy of LN
under controlled household conditions. In our trial the mortality of host-seeking An. gambiae
s.l. exposed to the standard pyrethroid-only Interceptor1 LN was less than 20%. This low mor-
tality response is typical of other pyrethroid-only LN evaluated in Benin and is because the
main vector species An. coluzzii has developed high-level resistance to alpha-cypermethrin
(207 fold) through a combination of L1014F kdr and CYP6P3 P450 mechanisms [8, 9]. Such
was the strength of the resistance that a 10-fold difference in the surface content of alpha-
cypermethrin between the unwashed and 20-times washed Interceptor1 LN made little or no
difference to the poor efficacy of the net or to the high proportion of mosquitoes surviving
(82% and 89% over 20 washes). To put this result into context, comparison can be made with
an earlier hut trial in an area of pyrethroid susceptibility (located in Tanzania) against the
same unwashed and 20 times washed Interceptor1 LN treatments when only 8% and 24% of
host-seeking An. gambiae, respectively, survived exposure [24].
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Interceptor1 G2 LN restored the capacity of long lasting insecticidal nets to control
highly resistant populations of An. gambiae s.l. The demonstration of 71% mortality with the
unwashed mixture LN, decreasing over 20 washes by only 6% approaches the high level of effi-
cacy once shown by pyrethroid-only LN when An. gambiae populations were fully susceptible
[24]. Chemical analysis and scanning electron micrographs confirmed that both insecticides
were closely bound to netting fibres by the formulation and were wash resistant and bio-avail-
able. To our knowledge this is the first demonstration of a non-pyrethroid insecticide to be
rendered wash resistant through binding technology within a LN ‘coating’ formulation and is
a significant achievement in its own right. Chlorfenapyr made the larger contribution to mos-
quito mortality in the hut trial, whilst the alphacypermethrin component made an important
contribution to blood feeding inhibition and personal protection, as indicated by the similarity
of response between mixture LN and pyrethroid-only LN. Blood-feeding inhibition ranged
from 60% to 50% with the unwashed and 20-times washed Interceptor G2 LN as compared
with 57% to 47% with Interceptor LN. This contrasts with 74% to 66% blood-feeding inhibi-
tion once observed with unwashed and 20-times washed Interceptor LN in hut trials in Tanza-
nia which suggests there is some loss of personal protection in Benin due to resistance relative
to regions of pyrethroid susceptibility [24]. While Interceptor G2 would continue to provide
personal protection to individual users in pyrethroid resistant areas it is recommended that
deployment is done to universal coverage so entire villages can benefit from the community
protection which arises from the mass killing of mosquito populations when an effective LN is
taken to scale and which a standard pyrethroid-only LN would no longer provide. Beyond
Benin, deployment of the mixture LN should extend and restore effectiveness in the many
places being compromised by resistance mediated by kdr in combination with metabolic
mechanisms [3–5, 9, 25].
Chlorfenapyr has a reputation for slow action and ‘delayed’ toxic activity 2–3 days post
exposure [11, 26]. This characteristic is particularly evident in daytime bioassays such as the
cone test but not necessarily observed in field situations. For example, in the present hut trial
two-thirds of total mortality had occurred by the morning after exposure. Chlorfenapyr seems
to be more toxic to mosquitoes during exposure at night when cellular respiration and meta-
bolic activity, under control of their circadian rhythm, are at their peak [26]. With exposure to
chlorfenapyr only occurring when anophelines are actively host seeking, the mosquito net is
an ideal means of optimizing exposure to the time when mosquitoes are most vulnerable to
this insecticide. With most mosquitoes succumbing within hours of exposure, this insecticide
is no less potent than many neurotoxic insecticides.
To meet the WHO Pest Evaluation Scheme criteria for recommendation as a long lasting
insecticidal net the candidate net should attain a threshold efficacy in Phase I cone or tunnel
test against a standard insecticide susceptible strain [19]. Interceptor G2 LN did not achieve
the WHO cone test threshold of 80% mortality but it did meet the tunnel test threshold of 80%
mortality and 90% blooding feeding inhibition in LN washed 20 times, and would therefore
pass Phase I. The cone test was a poor predictor of Interceptor G2 and chlorfenapyr CTN effi-
cacy in experimental huts. The tunnel test was a better predictor because exposure occurs at
night when host seeking mosquitoes are more vulnerable to chlorfenapyr. This raises a ques-
tion about the suitability of daytime bioassay techniques like the cone test as a screening tool
for identifying toxic activity of insecticides which are non-neurotoxic. Novel, effective insecti-
cides such as the pyrroles might easily be missed during initial screens. The tunnel test which
mimics insecticide exposure as it occurs in the field at night against host seeking mosquitoes is
a more reliable technique regardless of the mode of action of the insecticide under test and
should therefore be raised in importance and used more widely.
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To attain the bioassay efficacy criteria set by the WHO Vector Control Action Group for
recommendation against pyrethroid resistant mosquitoes the mixture LN is expected to attain
25% improvement in mortality or inhibition of blood feeding after 20 standardized washes rel-
ative to the pyrethroid-only LN [20]. Interceptor G2 failed to meet this threshold in cone test,
for the reasons already discussed, but attained a 3-fold improvement in mortality over the
pyrethroid-only LN in the tunnel tests which is well above the VCAG threshold.
The WHO cone and tunnel tests conducted on nets previously used in the experimental hut
trials help to interpret hut trial results against wild free-flying mosquitoes. In the present Phase
II experimental hut trials Interceptor G2 LN attained: 1) the WHOPES efficacy criteria of mor-
tality and blood feeding inhibition equal or better than standard pyrethroid-only LN [19], and
2) the WHO VCAG efficacy criteria of mortality or blood feeding inhibition significantly bet-
ter than pyrethroid-only LN against local highly resistant mosquitoes [20]. Relative to standard
pyrethroid-only Interceptor LN, the Interceptor G2 LN demonstrated a 3–4 fold improvement
in percentage mortality. This represents a major advance over the pyrethroid-only LN that are
currently being deployed by malaria control programs.
Apart from standard pyrethroid-only LN the only long-lasting net to be currently recom-
mended by WHOPES is co-impregnated with the synergist PBO (piperonyl butoxide). This
synergist is able to neutralize certain kinds of MFO responsible for metabolic resistance. In
hut trials in Benin, the PBO LN, PermaNet 3.0 killed 44% A. gambiae (control corrected)
when unwashed but after 20 washes killed only 18% which was a similar proportion killed by
the 20 times washed pyrethroid-only LN [8]. This contrasts with the 70% killed (control cor-
rected) by the unwashed Interceptor1 G2 LN in the present trial and 64% killed after 20
washes.
On the basis of these findings Interceptor1 G2 should attain WHOPES interim approval as
a LN for use in malaria control. Both types of LNs trialed in the experimental huts showed little
or no decrease in chemical content by the end of trial. Full WHOPES approval would require
Phase III trials of effectiveness over 3 years of household use. Previous Phase III studies of
Interceptor LN and comparison of outcomes of experimental hut and household trials showed
that alpha-cypermethrin losses after 3 years of household use were consistent with alpha-
cypermethrin losses after 20 Phase II standardized washes and trialing in experiment huts
[27]. If this relationship holds true for Interceptor1 G2 too, the satisfactory Phase II outcome
of the present experimental hut trial would predict a similar outcome following 3 years of
household use.
Conclusion
Selection of resistance to pyrethroid insecticides is the gravest threat to future progress in
malaria control. The development of new insecticides suitable for long lasting nets is vital for
preservation of this incomparable vector control tool. The mixture LN Interceptor1 G2 sur-
passed the efficacy and wash-resistance thresholds set by WHO and demonstrated capacity to
protect individual users and control highly pyrethroid-resistant mosquitoes bearing kdr and
metabolic mechanisms in small-scale field trial. Roll-out of Interceptor1 G2 is urgently
required to meet the needs of malaria control, particularly in areas affected by increasing levels
of insecticide resistance.
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